Plné znění - 261/2015 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2016

261/2015 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

261

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxxx

xx dne 22. xxxx 2015

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2016

 

Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. x) zákona x. 258/2000 Xx., x xxxxxxx veřejného xxxxxx a o xxxxx některých xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx rok 2016:

1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx očkování

1a) kombinovaná xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx forma), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x (XXxXXxxXXXXXX):

Xxxxxxxxxxx xxxxxxxxxx1 ne xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)

Xxxxxx xxxxxxxxxx1 xx xxxx než 40 xxxxxxxxxxxxx xxxxxxxx (XX)

Xxxxxxxx Xxxxxxxxxx pertussis:

Pertussis xxxxxxxxxx1 25 xxxxxxxxxx

Xxxxxxxxxxxxxxxx xxxxxxxxxxxx1 25 xxxxxxxxxx

Xxxxxxxxxxx1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx (xxxxxxxxxxxx)

xxxxx 1 (xxxx Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx

xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx xxxxx b xxxxxxxxxxxxxxx 10 xxxxxxxxxx

(xxxxxxxxxxxxxxxxxxx xxxxxxxx)3

xxxxxxxxx xxx xxxxxx xxxxxxxxxx xxxx xxxxxx xxxxxxxxx přibližně 25 xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx xxxxxxxx xxxxx proti záškrtu, xxxxxxxx xxxxx (acelulárni xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x (DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX)2

Xxxxxx xxxxxxxxxx xx xxxx než 40 xxxxxxxxxxxxx xxxxxxxx (XX)2

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx

Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx

Xxxxx Poliomyelitidis (xxxxxxxxxxxx)3

xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx4

xxxxx 2 (MEF-1) 8 X jednotek xxxxxxxx4

xxxxx 3 (Xxxxxxx) 32 X jednotek xxxxxxxx4

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X5 10 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx 12 mikrogramů

(Polyribosylribitoli xxxxxxxx)

xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu (XXxX):

Xxxxxxxxxxx anatoxinum ≥ 30 xxxxxxxxxxxxx jednotek

Tetani anatoxinum ≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (PT) 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 mikrogramů

Pertactinum (69xX) 8 xxxxxxxxxx

XXXX

1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, tetanu x xxxxxxxx xxxxx (acelulární)

1 xxxxx (0,5 ml) xxxxxxxx:	Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxxxxxxx anatoxinum
Tetani xxxxxxxxxx	Xxxxxxxxx 20 IU* (5 Lf)
Pertusové xxxxxxxx
Xxxxxxxxx xxxxxxxxxx	2,5 mikrogramu
Haemagglutinum xxxxxxxxxxxx	5 xxxxxxxxxx
Xxxxxxxxxxx	3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3	5 xxxxxxxxxx
Xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx	1,5 mg (0,33 xx xxxxxxx)

XXXX

1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx a xxxxxxxx xxxxx (acelulární xxxxxxxxxx) xx xxxxxxxx obsahem xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx než 2 xxxxxxxxxxx jednotky (XX) (2,5 Xx)

Xxxxxx xxxxxxxxxx1 xx xxxx než 20 mezinárodních xxxxxxxx (XX) (5 Xx)

Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1

8 mikrogramů

Pertussis xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx

1 adsorbováno xx xxxxxxxxxxx xxxxxxxx xxxxxxx (XX(XX)3) 0,3 xxxxxxxxx XX3+ x fosforečnan xxxxxxx (XXXX4) 0,2 xxxxxxxxx XX3+

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, nákazám xxxxxxxxx Hemofilem xxxxxxxxxx x (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx	xxx. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx	xxx. 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (PT)	25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)	25 xxxxxxxxxx
Xxxxxxxxxxx (69xX)	8 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx X	10 xxxxxxxxxx
xxx xxxxxxxxx xxxxxxxx	20-40 xxxxxxxxxx

1x) očkovací xxxxx xxxxx nákazám xxxxxxxxx Xxxxxxxxxxx influenzae xxx x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx xxxxxx:

Xxxxxx xxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx virové hepatitidě X xx 16 xxx x výše:

Antigenum xxxxxxxxx xxxxxxxxxxx B ... 20 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx virus xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxx xxxxx attenuatum (Xxxxxx RA 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx₅₀

1x) očkovací xxxxx xxxxx dětské xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Xxxxxxx) ... 40 xxxxxxxxxxx X jednotek*

Virus poliomyelitis xxxxxxxxxxx xxxxx 2 (XXX-1) ......... 8 xxxxxxxxxxx X jednotek*

Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ...... 32 xxxxxxxxxxx D xxxxxxxx*

* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx vhodné xxxxxxxxxxxxx xxxxxx.

1xx) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxxxx xxxxxxxxxx v xxxxxxxxxxxxxxx formuli:

Polysaccharidum Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7F, 8, 9X, 9X, 10X, 11X, 12F, 14, 15X, 17X, 18X, 19X, 19F, 20, 22X, 23F, 33X ... 25 xxxxxxxxxx x xxxxxxx sérotypu

1i) xxxxxxxx látka xxxxxxxxxxx xxxxx xxxxxxxxxxxxx infekcím:

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 1

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4

Pneumococcale xxxxxxxxxxxxxxx sérotypus 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6A

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 6B

Pneumococcale xxxxxxxxxxxxxxx sérotypus 7F

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 9V

Pneumococcale xxxxxxxxxxxxxxx sérotypus 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18C

Pneumococcale xxxxxxxxxxxxxxx sérotypus 19A

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx anatoxinum	ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx
Xxxxxx anatoxinum	ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx	8 mikrogramů
Pertussis haemagglutinum xxxxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx	2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx)	40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)	8 D xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)	32 X xxxxxxxx antigenu

NEBO

1ja) očkovací xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx	xxxx nebo xxxxx 2 mezinárodní xxxxxxxx (2 Xx)
Xxxxxxxxx xxxxxx	xxxx nebo rovno 20 mezinárodních xxxxxxxx (5 Lf)

Pertusové antigeny:

Pertusový xxxxxx	2,5 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxxxx	5 xxxxxxxxxx
Xxxxxxx xxxx 2+3	5 xxxxxxxxxx
Xxxxxxxxx	3 mikrogramy

-

Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx)	40 xxxxxxxxxxx X xxxxxxxx
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx)	8 antigenních X xxxxxxxx
Xxxxx poliomyelitis typu 3 (inaktivovaný)	32 antigenních X xxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxxxxxxx:

Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (BCG) xxxxxxx Danisuc 1331.....0,75 xx

&xx;2,0 x 10⁶ ≤ 8,0 x 10⁶ CFU (živých xxxxxxx)

1x) očkovací látka xxxxx xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; adjuvans XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 mikrogramů x 1 dávce

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx

2x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X ... 20 mikrogramů

2b) xxxxxxxx xxxxx xxxxx xxxxxxxxx

Xxxxx rabiei xxxxxxxxxxx (xxxx Xxxxxx rabies XX/XX 38&xxxx;1503-3X xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 dávce (0,5 xx)

2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X ve formuli xxx xxxxxxx:

Xxxxxxxxx X xxxxx inactivatum

3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx pro xxxxxxx:

Xxxxxxxxx X xxxxx xxxxxxxxxxx

3x) očkovací látka xxxxx xxxxxx hepatitidě X ve xxxxxxx xxx děti:

Virus hepatitis X inactivatum

 

V roce 2016 s xxxxxxx xx xxxxxxxxxx novelizaci xxxxxxxx č. 537/2006 Sb., x xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, xx xxxxx xxxxxxxxxx předpisů, xxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxxx složení xxxxxxxxxx xxxxx xxx pravidelná xxxxxxxx xxxxxxxxxxxx nového xxxxxxxxxxx složení těchto xxxxxxxxxx xxxxx ve Xxxxxx xxxxxx.

 

Xxxxxxx:

x x. XXXx. Policar x. x.

xxxxxxxx xxx legislativu x xxxxx

Informace

Právní xxxxxxx x. 261/2015 Xx. nabyl xxxxxxxxx xxxx 24.10.2015.

Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxxxx právním xxxxxxxxx x.:

131/2016 Xx., kterým xx mění xxxxxxx x. 261/2015 Xx., x xxxxxxxxxx složení xxxxxxxxxx látek xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx očkování xxx xxx 2016

s účinností xx 10.5.2016

Znění jednotlivých xxxxxxxx norem jiných xxxxxxxx předpisů x xxxxxxxx není xxxxxxxxxxxxx, xxxxx xx jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.